Breakout Session
Securing the Innovation Pipeline: Strategies for Protecting Next Generation Therapies
March 23, 2026 @ 9:15 AM EST – Knowles IP Room
9:15 AM ET
March 23, 2026
Securing the Innovation Pipeline: Strategies for Protecting Next Generation Therapies
For life sciences companies, the innovation pipeline is the business. As therapies grow more complex—spanning biologics, cell and gene therapies, platforms, combination products, and AI-enabled discovery—the risk profile surrounding protection, exclusivity, and value capture has never been higher.
This panel examines how companies can secure next-generation therapies from discovery through commercialization by deploying integrated protection strategies that align patents, regulatory exclusivities, trade secrets, and contracting discipline. Panelists will explore how to identify protectable innovation early, manage disclosure risk during clinical development, and design portfolios that withstand validity challenges while supporting partnering, licensing, and acquisition.
The discussion will address real-world issues, including platform versus product claiming, follow-on innovation, manufacturing and process protection, global filing strategy, freedom-to-operate risk, and the impact of PTAB and international enforcement trends. Panelists will also examine howthe exclusivity strategy influences valuation, investor confidence, and deal terms.
Survey: https://www.surveymonkey.com/r/Securing-the-Innovation-Pipeline
For life sciences companies, the innovation pipeline is the business. As therapies grow more complex—spanning biologics, cell and gene therapies, platforms, combination products, and AI-enabled discovery—the risk profile surrounding protection, exclusivity, and value capture has never been higher. This panel examines how companies can secure next-generation therapies from discovery through commercialization by deploying integrated protection strategies that align patents, regulatory…
